Bessemer Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.04M Sell
45,799
-22
-0% -$1.86K ﹤0.01% 760
2026
Q1
$4.55M Buy
45,821
+12,812
+39% +$1.67M 0.01% 513
2025
Q4
$4.02M Buy
33,009
+32,766
+13,484% +$4.11M 0.01% 478
2025
Q3
$27K Buy
243
+70
+40% +$8.19K ﹤0.01% 1608
2025
Q2
$23K Buy
173
+16
+10% +$1.76K ﹤0.01% 1539
2025
Q1
$11K Buy
157
+104
+196% +$7.15K ﹤0.01% 1746
2024
Q4
$3K Buy
53
+23
+77% +$2.14K ﹤0.01% 2162
2024
Q3
$5K Buy
+30
New +$4.62K ﹤0.01% 1953
2021
Q1
Sell
-1,400
Closed -$28K 1638
2020
Q4
$28K Sell
1,400
-400
-22% -$5.92K ﹤0.01% 1116
2020
Q3
$25K Sell
1,800
-900
-33% -$15.4K ﹤0.01% 1025
2020
Q2
$48K Buy
+2,700
New +$42.2K ﹤0.01% 1351

Other funds holding TMDX

Bessemer Group's TMDX Position: Q2 2026 in Review

Bessemer Group reduced its Transmedics (TMDX) stake by 0.05% in Q2 2026, selling an estimated $1.86K and leaving 45,799 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Bessemer Group first reported a position in TMDX in Q2 2020 and has held it in 11 quarters since. The position peaked at $4.55M in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Bessemer Group held 45,799 shares of Transmedics worth $3.04M as of Q2 2026.
  • Bessemer Group sold 22 Transmedics shares in Q2 2026, an estimated $1.86K.
  • Transmedics made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #760 holding.
  • Bessemer Group first reported a position in Transmedics in Q2 2020 and has held it in 11 quarters since.
  • Bessemer Group's Transmedics position peaked at $4.55M in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.